Balaji K Subramanian, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Podocytes | 6 | 2024 | 398 | 2.000 |
Why?
|
| Glomerulosclerosis, Focal Segmental | 3 | 2024 | 335 | 1.310 |
Why?
|
| Kidney Tubules | 1 | 2018 | 448 | 0.530 |
Why?
|
| Microfilament Proteins | 1 | 2016 | 1130 | 0.370 |
Why?
|
| Bioengineering | 2 | 2021 | 99 | 0.330 |
Why?
|
| Mice, Knockout | 1 | 2024 | 14392 | 0.320 |
Why?
|
| Acute Kidney Injury | 2 | 2018 | 1923 | 0.290 |
Why?
|
| Kidney Diseases | 3 | 2024 | 2092 | 0.280 |
Why?
|
| Charcot-Marie-Tooth Disease | 1 | 2024 | 100 | 0.220 |
Why?
|
| AIDS-Associated Nephropathy | 1 | 2021 | 34 | 0.190 |
Why?
|
| Cytoplasmic Dyneins | 1 | 2020 | 24 | 0.180 |
Why?
|
| Adenosine Deaminase | 1 | 2022 | 250 | 0.180 |
Why?
|
| Kidney Glomerulus | 1 | 2021 | 567 | 0.160 |
Why?
|
| Interferon Type I | 1 | 2022 | 557 | 0.160 |
Why?
|
| Organoids | 1 | 2024 | 744 | 0.150 |
Why?
|
| Dimethylpolysiloxanes | 1 | 2018 | 142 | 0.150 |
Why?
|
| Porosity | 1 | 2018 | 348 | 0.150 |
Why?
|
| Kidney Diseases, Cystic | 1 | 2018 | 182 | 0.140 |
Why?
|
| Membranes, Artificial | 1 | 2018 | 366 | 0.140 |
Why?
|
| Protamines | 1 | 2016 | 112 | 0.130 |
Why?
|
| rhoA GTP-Binding Protein | 1 | 2016 | 235 | 0.120 |
Why?
|
| rho GTP-Binding Proteins | 1 | 2016 | 275 | 0.120 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2016 | 696 | 0.120 |
Why?
|
| Necrosis | 1 | 2018 | 1610 | 0.110 |
Why?
|
| Biological Transport | 1 | 2018 | 2080 | 0.110 |
Why?
|
| Mice | 7 | 2024 | 81326 | 0.110 |
Why?
|
| Phenotype | 2 | 2024 | 16575 | 0.110 |
Why?
|
| Cisplatin | 1 | 2018 | 1652 | 0.100 |
Why?
|
| Animals | 8 | 2024 | 168079 | 0.100 |
Why?
|
| Membrane Proteins | 2 | 2020 | 7851 | 0.100 |
Why?
|
| Disease Models, Animal | 2 | 2024 | 18220 | 0.100 |
Why?
|
| Cells, Cultured | 2 | 2018 | 18926 | 0.100 |
Why?
|
| Mitochondria | 1 | 2024 | 3620 | 0.090 |
Why?
|
| Point Mutation | 1 | 2016 | 1593 | 0.090 |
Why?
|
| Autophagy | 1 | 2019 | 1327 | 0.090 |
Why?
|
| Extracellular Matrix | 1 | 2018 | 1720 | 0.090 |
Why?
|
| Kidney | 2 | 2021 | 7033 | 0.080 |
Why?
|
| Heparin | 1 | 2016 | 1632 | 0.080 |
Why?
|
| Actins | 1 | 2016 | 2046 | 0.080 |
Why?
|
| Mutation | 2 | 2024 | 30002 | 0.080 |
Why?
|
| Epithelial Cells | 1 | 2018 | 3671 | 0.070 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2016 | 2871 | 0.070 |
Why?
|
| Phosphorylation | 1 | 2016 | 8300 | 0.060 |
Why?
|
| Cell Line | 1 | 2018 | 15545 | 0.060 |
Why?
|
| Apoptosis | 1 | 2018 | 9477 | 0.050 |
Why?
|
| Inosine | 1 | 2022 | 129 | 0.050 |
Why?
|
| HEK293 Cells | 2 | 2022 | 4243 | 0.050 |
Why?
|
| Chromosomes, Artificial, Bacterial | 1 | 2021 | 123 | 0.050 |
Why?
|
| RNA Editing | 1 | 2022 | 149 | 0.050 |
Why?
|
| RNA, Double-Stranded | 1 | 2022 | 290 | 0.050 |
Why?
|
| 3' Untranslated Regions | 1 | 2022 | 514 | 0.040 |
Why?
|
| Mice, Transgenic | 2 | 2022 | 9520 | 0.040 |
Why?
|
| Humans | 8 | 2024 | 761208 | 0.040 |
Why?
|
| Ion Channels | 1 | 2022 | 1038 | 0.040 |
Why?
|
| Adenosine | 1 | 2022 | 805 | 0.040 |
Why?
|
| Endosomes | 1 | 2019 | 518 | 0.030 |
Why?
|
| Antineoplastic Agents | 1 | 2018 | 13632 | 0.030 |
Why?
|
| Protein Transport | 1 | 2020 | 1958 | 0.030 |
Why?
|
| Interferon-gamma | 1 | 2022 | 3155 | 0.030 |
Why?
|
| Lysosomes | 1 | 2019 | 921 | 0.030 |
Why?
|
| Cell Culture Techniques | 1 | 2020 | 1662 | 0.030 |
Why?
|
| Signal Transduction | 1 | 2016 | 23416 | 0.030 |
Why?
|
| Endoplasmic Reticulum | 1 | 2019 | 1125 | 0.030 |
Why?
|
| RNA, Messenger | 1 | 2022 | 12747 | 0.020 |
Why?
|
| Genetic Variation | 1 | 2019 | 6567 | 0.010 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2021 | 17897 | 0.010 |
Why?
|
| Risk Factors | 1 | 2019 | 74239 | 0.010 |
Why?
|